Some cancers (like lung, bladder, and pancreatic) can cause a condition called cachexia, where people lose muscle and feel weak—especially men. Scientists looked at a molecule called miR-486 that helps keep muscles strong. They found that people with these cancers had much lower levels of miR-486 in their blood—and the drop was biggest in men. To understand why, researchers studied blood samples from people stored at the Komen Tissue Bank, tested it in mice, and grew muscle cells in the lab.
They discovered that estrogen and a drug similar to estrogen (toremifene) can raise miR-486 levels. That boost helps turn on a muscle-strengthening system inside cells and blocks inflammation that normally weakens muscles. This explains why women—who naturally have more estrogen—tend to keep their muscles better during cancer, and highlights miR-486 as a key target for new treatments, especially for patients with low estrogen.
